GBT Historical Earnings image   This GBT historical earnings page last updated 11/11/2022
GBT Historical Revenue
PeriodHistorical Earnings DateRevenue
Q2 20228/8/20220.07B
Q1 20225/4/20220.06B
Q4 20212/23/20220.06B
Q3 202111/4/20210.05B
Q2 20218/3/20210.05B
Q1 20215/5/20210.04B
Q4 20202/24/20210.04B
Q3 202011/5/20200.04B
Q2 20208/5/20200.03B
Q1 20205/6/20200.01B
Q4 20192/26/20200.00B
Q3 201911/7/2019NA
Q2 20198/7/2019NA
Q1 20195/8/2019NA
Q4 20182/27/2019NA
Q3 201811/6/2018NA
Q2 20188/2/2018NA
Q1 20185/7/2018NA
Q4 20172/27/2018NA
Q3 201711/2/2017NA
Q2 20178/7/2017NA
Q1 20175/1/2017NA
Q4 20163/13/2017NA
Q3 201611/9/2016NA
Q2 20168/10/2016NA
Q1 20165/12/2016NA
Q4 20153/29/2016NA
Q3 201511/12/2015NA
Q2 20159/24/2015NA
Q3 201411/14/2014NA
Q2 20149/25/2014NA
GBT Historical Earnings EPS
PeriodHistorical Earnings DateEarnings
Q2 20228/8/2022-1.260
Q1 20225/4/2022-1.260
Q4 20212/23/2022-1.360
Q3 202111/4/2021-1.130
Q2 20218/3/2021-1.120
Q1 20215/5/2021-1.210
Q4 20202/24/2021-1.000
Q3 202011/5/2020-0.970
Q2 20208/5/2020-0.860
Q1 20205/6/2020-1.200
Q4 20192/26/2020-1.590
Q3 201911/7/2019-1.070
Q2 20198/7/2019-1.010
Q1 20195/8/2019-0.870
Q4 20182/27/2019-0.93
Q3 201811/6/2018-0.83
Q2 20188/2/2018-0.78
Q1 20185/7/2018-0.87
Q4 20172/27/2018-0.94
Q3 201711/2/2017-0.66
Q2 20178/7/2017-0.55
Q1 20175/1/2017-0.6
Q4 20163/13/2017-0.74
Q3 201611/9/2016-0.58
Q2 20168/10/2016-0.58
Q1 20165/12/2016-0.56
Q4 20153/29/2016-0.53
Q3 201511/12/2015-0.9
Q2 20159/24/2015-4.84
Q3 201411/14/2014-3.53
Q2 20149/25/2014-3.68
Quotes delayed 20 minutes

Email EnvelopeFree GBT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Global Blood Therapeutics (GBT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

GEG Historical Earnings
GERN Historical Earnings
GH Historical Earnings
GILD Historical Earnings
GKOS Historical Earnings
GLSI Historical Earnings
GLUE Historical Earnings
GLYC Historical Earnings
GMED Historical Earnings
GMTX Historical Earnings
What was the record high GBT historical earnings result?
In terms of earnings or revenue, what is the best GBT historical earnings result that Global Blood Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest GBT historical earnings result was set in Q4 2015, when Global Blood Therapeutics posted results of -0.53/share. The most successful revenue quarter within our data set was Q2 2022 when Global Blood Therapeutics reported revenue of 0.07B.

What was the lowest Global Blood Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest GBT has reported, and when?

✔️Accepted answer: Within our data set, the lowest GBT historical earnings result was set in Q2 2015, when Global Blood Therapeutics posted results of -4.84/share. The smallest revenue quarter within our data set was Q3 2019 when Global Blood Therapeutics reported revenue of NA.

On this page we presented the GBT historical earnings date information for Global Blood Therapeutics. Reviewing that GBT Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2015, when GBT posted earnings of -0.53/share. Meanwhile the lowest GBT historical earnings result was in Q2 2015, when GBT posted earnings of -4.84/share. Moving to Global Blood Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when GBT reported 0.07B in revenue, while the smallest revenue quarter was Q3 2019 when GBT reported NA in revenue.

For self directed investors doing their due diligence on GBT or any other given stock, their research can benefit from looking into all of the Global Blood Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you to make it more convenient for investors to look into Global Blood Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for GBT. Thanks for visiting, and the next time you need to research GBT historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Syndax Pharmaceuticals Earnings History, SPAN Insider Buying, Berkshire Hathaway RSI.


GBT Historical Earnings | | Copyright © 2020 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.